Patrick Brunner, MD
Enriched profileAssociate Professor of Dermatology and Director of the Cutaneous Lymphoma Clinic, Kimberly and Eric J. Waldman Department of Dermatology · Icahn School of Medicine at Mount Sinai
Patrick Brunner is Associate Professor of Dermatology and Director of the Cutaneous Lymphoma Clinic, Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 277 publications with 7,288 citations (h-index 43); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Data verified 24 Aug 2026
Overview
Updated 16 Oct 2026
Patrick M. Brunner, MD, is Associate Professor of Dermatology and Director of the Cutaneous Lymphoma Clinic, Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai. The public record shows 277 publications with 7,288 citations (h-index 43), centered on Dermatology and Skin Diseases, Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 29 companies, 2 NIH-funded awards (2025–2026).
- Most recent indexed publication: 2026 · Journal of the European Academy of Dermatology and Venereology
- Top research focus: Dermatology and Skin Diseases
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 29 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 80.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Ritlecitinib in CTCL
Sponsor: Icahn School of Medicine at Mount Sinai
- Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
Sponsor: Rockefeller University
Industry payments
Updated 16 Oct 2026
29 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20259 payments$14,211openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20253 payments
- Immunocore LimitedProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
20.5%Corticosteroid17%Triamcinolone Acetonide100%Part D≥46 patientsInterleukin-4 Receptor alpha Antagonist3.5%Dupixent Syringe100%Part D<11 patientsCancer & immunology
18.6%Kinase inhibitor6.5%Opzelura100%Part D<11 patientsInterleukin-17A Antagonist6.2%Taltz Autoinjector100%Part D<11 patients+ 1 more class in this area
Anti-infectives
18.1%Azole Antifungal18.1%Ketoconazole100%Part D≥33 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2025–2026 per NIH RePORTER. The latest:
- T-cell plasticity mediating treatment resistance and side effects in atopic dermatitis
Icahn School of Medicine at Mount Sinai
FY2026$500,516R01AR083960 - Research Training in Systems Skin Biology
Icahn School of Medicine at Mount Sinai
FY2026$245,578T32AR082315 - T-cell plasticity mediating treatment resistance and side effects in atopic dermatitis
Icahn School of Medicine at Mount Sinai
FY2025$528,558R01AR083960
Congress activity
Updated 16 Oct 2026
1 congress contribution (2025) across ASH per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- scRNA-Seq reveals anti-lymphoma immune responses in mogamulizumab-associated skin eruptions.
Journal of the European Academy of Dermatology and Venereology
Article2026 - Molecular Markers Distinguishing Early-Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions.
Experimental dermatology
Article2026 - Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation.
Nature communications
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
scholars.mssm.edu/en/persons/5e95ad0b-234f-43eb-a333-6a698e77a7e5
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗ - Other
scopus.com/authid/detail.uri
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scopus.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Patrick-M-Brunner-2174432226
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/drpbrunner
Mentions by others
where others cite or feature them- Facebook
facebook.com/MountSinaiDerm/photos/dr-patrick-brunner-and-team-attended-eortc-cutaneous-lymphoma-tumour-group-annua/524297470342884
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - X / Twitter
x.com/MSHSDerm/status/1988633826449309735
- X / Twitter
x.com/MSHSDerm/status/1996722107737133274
- X / Twitter
Mount Sinai Dermatology (@MSHSDerm) on X: covered Brunner's talk "What's new in Cutaneous Lymphomas" at Derm Winter Symposium 2025, discussing dupilumab/CTCL controversy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗ - X / Twitter
Mount Sinai Dermatology (@MSHSDerm) on X: Brunner opened the Symposium on Malignant Skin Inflammation at ISDS 2025, presenting "Chronic Inflammation - lessons learned from CTCL"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MSc
Clinical and Translational Science, The Rockefeller University Laboratory of Investigative Dermatology
2018verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗ - MD
Medical University of Vienna, Austria (with highest academic honors)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗ - Dermatology residency
Department of Dermatology, Medical University of Vienna (General Hospital Vienna), under Dr. Georg Stingl
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholars.mssm.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Cutaneous Lymphoma Clinic, Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center, Mount Sinai
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗ - Member
Mount Sinai Academy of Physician-Scientists
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗ - Former Instructor in Clinical Investigation
The Rockefeller University (post-residency, prior to Mount Sinai)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prnewswire.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →americanskin.org ↗
- 2025 ASA Calder Investigative Scientist Award in Vitiligo
American Skin Association (project: "Tape-strip profiling of patients with vitiligo")
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →americanskin.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- OncLive video interview: "Dr Brunner on the Role of the Dermatologist in BPDCN Diagnosis and Treatment"
discusses dermatologist/oncologist collaboration in blastic plasmacytoid dendritic cell neoplasm diagnosis
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
Jedd Wolchok, MD
Weill Cornell Medicine
Mario Sznol, MD
University of Miami Miller School of Medicine
Kevin Brown, MD
National Cancer Institute
Patrick Ott, MD
Dana-Farber Cancer Institute